Intralipid 20%

Safety and Efficacy Study to Compare Smoflipid and Intralipid 20% in Pediatric Patients of 3 Months to 16 Years of Age

Phase 3 Study to Compare Safety and Efficacy of Smoflipid 20% to Intralipid 20% in Hospitalized Neonates and Infants

Free Fatty Acids-Induced Hypertension in Obese Subjects (Aim #2)

Mechanism Underlying Beta-cell Failure in Obese African Americans With History of Hyperglycemic Crises

Effect Of Intravenous IntralipidTherapyon Pregnancy Outcome in Women With History of Recurrent Implantation Failure Undergoing Intracytoplasmic Sperm Injection-Embryo Transfer Cycle: A Randomized Controlled Trial

Cardiac REperfusion With Intralipid® at Reperfusion

Assessment of Intralipid Efficacy in Women With Unexplained Recurrent Implantation Failure

Effect of Intralipid Infusion in Patients With Recurrent Implantation Failure

Evaluation of OMEGAVEN 10%® (n-3 EFA Lipid Emulsion) in Home Parenteral Nutrition-associated Liver Disease

A Study to Evaluate the Effect of Lipid Infusion on Toll Like Receptor 4 (TLR4) Signaling

Immune Modulation by Parenteral Fish Oil in Patients With Crohn's Disease

FFA Hypertension and Inflammation in Lean and Obese Subjects

Free Fatty Acid-Induced Hypertension in Obese Subjects With Type 2 Diabetes

The Effect of Intravenous Lipids on Lung Function in Acute Respiratory Distress Syndrome (ARDS)

Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants?

The Influence of Fatty-Acids on Systemic and Subcutaneous Cytokines